Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
By R. Yeh, E. Secemsky, D. Kereiakes, Sharon-Lise T Normand, A. Gershlick, David J Cohen, J. Spertus, P. Steg, D. Cutlip, M. Rinaldi and 6 more. Journal of the American Medical Association (JAMA), 2016
849 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/05a14eb1db94d31831b56de0732b5b359cf037f1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Surgery
Citations in the corpus
- Deep Survival : The Deep Cox Proportional Hazards Network (2016, background): “Medical researchers rely on survival models to evaluate the significance of prognostic variables in outcomes such as death or cancer recurrence and to inform treatment options [1, 2, 3, 4].”
- DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network (2016, background): “Medical researchers use survival models to evaluate the significance of prognostic variables in outcomes such as death or cancer recurrence and subsequently inform patients of their treatment options [1, 2, 3, 4].”
- Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials (2017, background): “Previously, several authors estimated models to improve personalized medicine by detecting heterogeneous treatment effects from clinical trial data [7,9,29].”